Re:Goldman Sachs questions whether curing patients is a sust...
by bonzini on Friday April 13, 2018 @06:18AM
(#16828533)
That's a 0.4/8.9 reduction, about 5%. However, flu vaccine isn't useful to the general population. In many countries is usually administered to people that are most likely to develop complications such as pulmonitis.
[ Parent
| on HN ]
Re:Goldman Sachs questions whether curing patients is a sust...
by dominotw on Friday April 13, 2018 @01:34PM
(#16832114)
> However, flu vaccine isn't useful to the general population.
CDC makes no such distinctions in USA.
https://www.cdc.gov/vaccines/hcp/vis/vis-statements/flu.html
Any references to your claims?
Re:Goldman Sachs questions whether curing patients is a sust...
by bonzini on Friday April 13, 2018 @02:41PM
(#16832780)
Italian only, but see item 11 of http://www.salute.gov.it/portale/p5_1_2.jsp?id=103 - should be easy for Google to translate it.
Though I should have written "isn't _equally_ useful to everyone in the general population".